Inglasia Pharma Solutions Ltd
07894288
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
secretary · Since 30/12/2011
director · Since 30/12/2011
ACCOUNTANT
BRITISH · UNITED KINGDOM · Age 46
Also on 1 other board
Persons with Significant Control
Mrs Anju Nadarajah
British · United Kingdom · Age 46
3rd Floor, 207, 3rd Floor, 207 Regent Street, London, W1B 3HH
Notified 01/06/2016
Former PSCs
Mr Sanjayan Nadarajah
Ceased 03/02/2020
CompanyRankvs 3543+ SIC 74909 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£14k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£344k
Working capital
Current Assets
£402k
Current Liabilities
£92k
Fixed Assets
£7k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 4.34 | -£22k |
| 2023 | 1.43 | +£16k |
| 2021 | 1.60 | +£3k |
| 2020 | 1.79 | +£29k |
| 2019 | 1.19 | -£16k |
| 2018 | 1.60 | — |
Derived from filed accounts. Not audited figures.